WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers

Identifier

017506

Type of Spiritual Experience

Hallucination

Number of hallucinations: 1

Background

A description of the experience

Ann Emerg Med. 2013 Sep;62(3):244-51. doi: 10.1016/j.annemergmed.2012.12.017. Epub 2013 Mar 26.

A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers.

Warrick BJ1, Hill M, Hekman K, Christensen R, Goetz R, Casavant MJ, Wahl M, Mowry JB, Spiller H, Anderson D, Aleguas A, Gummin D, Thomas R, Nezlek C, Smolinske S.

  • 1Children's Hospital of Michigan Regional Poison Center, Detroit, MI, USA. brandon_warrick@hotmail.com

STUDY OBJECTIVE:

A new generation of designer stimulants marketed as "bath salts" emerged in late 2010. The goal is to describe the epidemiologic emergence of designer stimulants in 9 states in the Midwest.

METHODS:

A retrospective review of the National Poison Data System was performed between November 1, 2010, and November 30, 2011. Inclusion criteria were health care-evaluated bath salts or other synthetic stimulants exposures. Cases were excluded if the exposure was unrelated to a designer stimulant. Demographic and clinical characteristics of cases were calculated and differences in outcome and exposure by generation were examined.

RESULTS:

One thousand six hundred thirty-three patients met the inclusion criteria. Age ranged from 1 day to 61 years (mean=29.2 years), with 67.9% male patients. The most common clinical features were

  • agitation (62.2%),
  • tachycardia (55.2%), and
  • hallucinations (32.7%).

In addition to 15.5% of patients having a major medical effect, 0.6% died. Reason for use was primarily intentional abuse (88.5%). However, 0.7% of patients reported withdrawal. Treatment involved primarily benzodiazepines (58.5%), with 8.7% of patients being intubated. Baby Boomers were more likely to have a major medical outcome (24.2%) and to report injection as the method of administration (8.6%-12.9%).

CONCLUSION:

Synthetic stimulants rapidly swept across the Midwest, resulting in more than 1,600 patients seeking medical care. Serious medical effects or death was observed in 16.1% of cases. Older generations were more likely to inject and to have a major medical outcome.

Copyright © 2013 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

PMID:

23540815

The source of the experience

PubMed

Concepts, symbols and science items

Concepts

Symbols

Science Items

Bath salts

Activities and commonsteps

Commonsteps

References